forecast
Non-Invasive Glucose Monitoring Is the Technology Risk
The second major risk is technological: a non-invasive glucose monitor that avoids penetrating the skin could displace current CGMs, and prior attempts such as Novartis's contact lens and GlucoWatch failed on accuracy and skin irritation.
forecastpending
Speaker
AnealEvidence Quote
“Dexcom and Abbott and the MiniMed device all go underneath the skin. One thing that I'm particularly focused on is non-invasive glucose monitoring.”
Created: 11/20/2026, 5:18:27 AM
Your notes
Loading notes...